These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 218452)

  • 1. Prostaglandin E and hypercalcemia in breast carcinoma: only a tumor marker? A need for perspective.
    Caro JF; Besarab A; Flynn JT
    Am J Med; 1979 Feb; 66(2):337-41. PubMed ID: 218452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
    Robertson RP; Baylink DJ; Metz SA; Cummings KB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma.
    Seyberth HW; Bonsch G; Müller H; Minne HW; Erlenmaier T; Strein K; Imbeck H; Mrongovius R
    Br J Cancer; 1980 Sep; 42(3):455-61. PubMed ID: 7426347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
    Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
    N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma prostaglandins in hypercalcemic patients with neoplastic disease.
    Demers LM; Allegra JC; Harvey HA; Lipton A; Luderer JR; Mortel R; Brenner DE
    Cancer; 1977 Apr; 39(4):1559-62. PubMed ID: 851945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
    Gottleib S; Rude RK; Sharp CF; Singer FR
    Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exocrine pancreatic cancer with humoral hypercalcemia.
    Monno S; Nagata A; Homma T; Oguchi H; Kawa S; Kaji R; Furuta S
    Am J Gastroenterol; 1984 Feb; 79(2):128-32. PubMed ID: 6695885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of hypercalcemia in malignancy.
    Besarab A; Caro JF
    Cancer; 1978 Jun; 41(6):2276-85. PubMed ID: 657092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.
    Robertson RP; Baylink DJ; Marini BJ; Adkison HW
    J Clin Endocrinol Metab; 1975 Jul; 41(1):164-7. PubMed ID: 1150858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercalcemia in large cell lymphoma. Possible role of prostaglandins E2 (author's transl)].
    Boissonnas A; Khalifa P; Sereni D; Mathiot C; Vacher-Lavenu MC; Hornych A; Cremer GA; Laroche C
    Ann Med Interne (Paris); 1982; 133(3):186-91. PubMed ID: 6954869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of prostaglandin E2, parathormone, and response to indomethacin in patients with hypercalcemia of malignancy.
    Brenner DE; Harvey HA; Lipton A; Demers L
    Cancer; 1982 Feb; 49(3):556-61. PubMed ID: 7059914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin-E-producing hepatocellular carcinoma with hypercalcemia.
    Ikeda T; Tozuka S; Hasumura Y; Takeuchi J
    Cancer; 1988 May; 61(9):1813-4. PubMed ID: 2833340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating parathyroid hormone-related protein (109-141) in malignancy-associated hypercalcemia.
    Nagasaki K; Otsubo K; Kajimura N; Tanaka R; Watanabe H; Tachimori Y; Kato H; Yamaguchi H; Saito D; Watanabe T; Adachi I; Yamaguchi K
    Jpn J Clin Oncol; 1996 Feb; 26(1):6-11. PubMed ID: 8551669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated prostaglandin and indomethacin-responsive hypercalcemia in a patient with malignant pheochromocytoma.
    Uchida T; Kuwao S; Ishibashi A; Koshiba K
    J Urol; 1985 Oct; 134(4):712-3. PubMed ID: 4032577
    [No Abstract]   [Full Text] [Related]  

  • 16. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral nonparathyroid hypercalcemia without evidence of bone involvement.
    Liberati AM; Di Costanzo F; Anasetti C; Buzzi F; Falchi R; Grignani F
    Tumori; 1983 Jun; 69(3):223-6. PubMed ID: 6306887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
    Coombes RC; Neville AM; Bondy PK; Powles TJ
    Prostaglandins; 1976 Dec; 12(6):1027-35. PubMed ID: 1005735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma.
    Tashjian AH; Voelkel EF; Levine L
    Biochem Biophys Res Commun; 1977 Jan; 74(1):199-207. PubMed ID: 836278
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandins and hypercalcemic states.
    Seyberth HW; Raisz LG; Oates JA
    Annu Rev Med; 1978; 29():23-9. PubMed ID: 348034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.